x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- Zumla, AlimuddinRemove Zumla, Alimuddin filter
- Ippolito, GiuseppeRemove Ippolito, Giuseppe filter
- Hui, David SRemove Hui, David S filter
Publication Date
Please choose a date range between 2020 and 2021.
Author
- Kock, Richard2
- Ntoumi, Francine2
- Abubakar, Aisha1
- Aklillu, Eleni1
- Al-Abri, Seif1
- Ansumana, Rashid1
- Asogun, Danny1
- Azhar, Esam I1
- Bates, Matthew1
- Blumberg, Lucille1
- Bockarie, Moses1
- Chakaya, Jeremiah1
- Dar, Osman1
- Drosten, Christian1
- Edwards, Sarah1
- Haider, Najmul1
- Hamid, Muzamil Mahdi Abdel1
- Himwaze, Cordelia M1
- I Azhar, Esam1
- Kaleebu, Pontiano1
- Kapata, Nathan1
- Kramer, Laura D1
- Madani, Tariq A1
Coronavirus (COVID-19) Collection
2 Results
- EditorialOpen Access
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
International Journal of Infectious DiseasesVol. 114p268–272Published online: December 1, 2021- Eskild Petersen
- Francine Ntoumi
- David S Hui
- Aisha Abubakar
- Laura D. Kramer
- Christina Obiero
- and others
Cited in Scopus: 100Nearly two years since the start of the SARS-CoV-2 pandemic, which has caused over 5 million deaths, the world continues to be on high COVID-19 alert. The World Health Organization (WHO), in collaboration with national authorities, public health institutions and scientists have been closely monitoring and assessing the evolution of SARS-CoV-2 since January 2020 (WHO 2021a; WHO 2021b). The emergence of specific SARS-CoV-2 variants were characterised as Variant of Interest (VOI) and Variant of Concern (VOC), to prioritise global monitoring and research, and to inform the ongoing global response to the COVID-19 pandemic. The WHO and its international sequencing networks continuously monitor SARS-CoV-2 mutations and inform countries about any changes that may be needed to respond to the variant, and prevent its spread where feasible. - EditorialOpen Access
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
International Journal of Infectious DiseasesVol. 91p264–266Published online: January 14, 2020- David S. Hui
- Esam I Azhar
- Tariq A. Madani
- Francine Ntoumi
- Richard Kock
- Osman Dar
- Giuseppe Ippolito
- Timothy D. Mchugh
- Ziad A. Memish
- Christian Drosten
- Alimuddin Zumla
- Eskild Petersen
Cited in Scopus: 2077The city of Wuhan in China is the focus of global attention due to an outbreak of a febrile respiratory illness due to a coronavirus 2019-nCoV. In December 2019, there was an outbreak of pneumonia of unknown cause in Wuhan, Hubei province in China, with an epidemiological link to the Huanan Seafood Wholesale Market where there was also sale of live animals. Notification of the WHO on 31 Dec 2019 by the Chinese Health Authorities has prompted health authorities in Hong Kong, Macau, and Taiwan to step up border surveillance, and generated concern and fears that it could mark the emergence of a novel and serious threat to public health (WHO, 2020a; Parr, 2020).
